Статья

Peptides: Prospects for Use in the Treatment of COVID-19

Khavinson, V., Linkova, N., Dyatlova, A., Kuznik, B., Umnov, R.,
2021

There is a vast practice of using antimalarial drugs, RAS inhibitors, serine protease inhibitors, inhibitors of the RNA-dependent RNA polymerase of the virus and immunosuppressants for the treatment of the severe form of COVID-19, which often occurs in patients with chronic diseases and older persons. Currently, the clinical e cacy of these drugs for COVID-19 has not been proven yet

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. от 2021-08-05

Метаданные

Об авторах
  • Khavinson, V.
  • Linkova, N.
  • Dyatlova, A.
  • Kuznik, B.
  • Umnov, R.
Тип документа
  • journal-article
Тип лицензии Creative Commons
  • CC-BY
Правовой статус документа
  • Свободная лицензия
Источник
  • openrepository.ru